Aegis Capital Starts MediWound Ltd (MDWD) at Buy

March 2, 2021 11:29 AM EST
Get Alerts MDWD Hot Sheet
Price: $4.99 --0%

Rating Summary:
    11 Buy, 0 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 18 | Down: 8 | New: 32
Trade Now! 
Join SI Premium – FREE

Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.

Aegis Capital analyst Nathan Weinstein initiates coverage on MediWound Ltd (NASDAQ: MDWD) with a Buy rating and a price target of $10.00.

Analyst comments: "We value shares using an EV/Sales multiple of 12x, based on our estimate of the ~peer average, applied to FY:22E sales of $20.1mm. We believe MDWD shares warrant this multiple due to our appraisal of the growth opportunities for its key products, including NexoBrid which has clearly differentiated itself in clinical trials."

For an analyst ratings summary and ratings history on MediWound Ltd click here. For more ratings news on MediWound Ltd click here.

Shares of MediWound Ltd closed at $5.48 yesterday.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Analyst Comments, New Coverage